Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New weight loss drugs could be developed much faster if Roche gets its way
Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop new drugs, including its slate of experimental weight loss and diabetes medications.
Popular Weight Loss Drugs Now for Patients With Cancer?
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes. But data on the practice remain limited.
New weight loss drugs spark eating disorder concerns in teens
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs, like Wegovy, have been approved for kids 12 and up and the number of teenagers taking these medications rose nearly sevenfold between 2020 and 2023.
Doctor: Eating the right foods can trigger weight-loss
According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1, which is what the injectable weight-loss drugs do.
As weight-loss drugs take off, doctor says these foods are just as powerful
According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what injectable weight-loss drugs do.
10d
Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects
Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
STAT
2h
$400 million for an obesity drug startup? A new venture is a sign of the times
Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...
verywellhealth
7d
Novo Nordisk's Experimental Oral Drug Reports 'Remarkable' Weight Loss, Early Data Shows
In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.
6d
on MSN
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...
ConsumerAffairs
10d
Weight loss pills vs. injections: Which is right for you?
Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...
2d
on MSN
WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
12d
Achieving Weight Loss: New Study Identifies Key Factors of Success
The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...
Oklahoma's News on MSN
4d
Competition explodes amid weight loss drug shortage
Eli Lilly, which manufacturers Mounjaro and Zepbound, announced six
new
lawsuits against compounding pharmacies ... legal ...
4d
F.D.A. Approves the First New Schizophrenia Drug in Decades
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback